Bio-Thera Secures FDA Approval For Sandoz-Partnered Bevacizumab Biosimilar
Avzivi Is The Second Bio-Thera Biosimilar – And The Second Chinese Biosimilar – To Secure FDA Approval
Bio-Thera has developed both biosimilars researched, developed and manufactured by a Chinese company to recieve US FDA approval • Source: Shutterstock 
